Gilero, a medical device manufacturer with two sites in North Carolina, is expanding to a third site in the state -- a new 60 ...

Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...

Kevin Nicusanti, Equity Funding Specialist at the Small Business and Technology Development Center, will de-mystify becoming investor-ready, understanding different types of investors, and how to ...

In modern medicine, however, medical devices and diagnostics are continuously evolving. So they may stand completely independent of one another. There are companies in North Carolina creating ...

Many facilities across North Carolina support life sciences research. The listing covers core laboratory facilities at university and nonprofit research institutions that are open to researchers or ...

Patients who have hereditary angioedema, or HAE, can experience sudden and rapid swelling, often in the feet, hands, and abdomen. These unexpected attacks can also close off airways, potentially ...

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences. North Carolina is home to 830 life ...

Gov. Roy Cooper announced today that Believer Meats, an Israeli company that is commercializing cultivated meat made from animal cells, plans to build a $123 million, 200,000-square-foot manufacturing ...

When technology impacts the food chain, sometimes the food chain bites back. Those kinds of lessons were the theme for the second day of the recent two-day North Carolina Biotechnology Center AgBio ...

Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...